+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient



Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient



Acta Medica Portuguesa 31(10): 593-596



O lúpus eritematoso sistémico é uma doença autoimune heterogénea e imprevisível, o que pode complicar a sua abordagem e tratamento. A linfohistiocitose hemofagocítica e a hemorragia alveolar difusa são complicações raras da doença. Os autores descrevem o caso de uma mulher de 32 anos, com lúpus e febre de origem indeterminada. Da investigação realizada, o mielograma revelou hemofagocitose e parasitas de Leishmania, pelo que iniciou anfotericina B lipossomal. Manteve febre apesar da terapêutica dirigida e evoluiu com hemorragia alveolar difusa. Repetiu mielograma, mantendo hemofagocitose já sem parasitas, tendo aumentado corticoterapia e iniciado imunoglobulina com melhoria. Dada a presença de síndrome de activação macrofágica e hemorragia alveolar difusa iniciou rituximab. Meses após a alta hospitalar, iniciou novamente febre sustentada e foram novamente identificados parasitas de Leishmania, pelo que reiniciou anfotericina B lipossomal associada a miltefosina. Mantém follow-up, encontrando-se assintomática e com corticóides em esquema de desmame.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 065969874

Download citation: RISBibTeXText

PMID: 30387429


Related references

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. Internal Medicine Journal 46(11): 1347-1348, 2016

Continous Rituximab treatment for recurrent diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus and antiphosholipid syndrome. Respiratory Medicine Case Reports 22: 263-265, 2017

Visceral leishmaniasis leading to macrophage activation syndrome. Medecine et Maladies Infectieuses 2019, 2019

Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis. Archives de Pediatrie 22(4): 397-400, 2015

Diffuse Alveolar Hemorrhage in a Lupus Patient With Systemic Cryptococcosis. Chest Journal 144(4): 62a-62b, 2013

Severe macrophage activation syndrome following visceral leishmaniasis in a child. Medecine et Sante Tropicales 24(2): 221-223, 2015

Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis. La Tunisie Medicale 77(12): 648-650, 2000

Inappropriate macrophage activation syndrome associated with visceral leishmaniasis in an infant. Tunisie Medicale 77(12): 648-650, 1999

Strongyloidiasis and Diffuse Alveolar Hemorrhage in a Patient With Systemic Lupus Erythematosus. Chest Journal 144(4): 241a-241b, 2013

CT appearance of diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. Acta Radiologica 34(6): 634-635, 1993

Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. Case Reports in Medicine 2014: 278390, 2014

Severe Progressive Diffuse Alveolar Hemorrhage in a Patient with Systemic Lupus Erythematosus. Case Reports in Critical Care 2018: 9790459, 2018

Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage. Case Reports in Rheumatology 2017: 6031053, 2017

Diffuse Alveolar Hemorrhage, A Potentially Life-Threatening Manifestation in Systemic Lupus Erythematosus and the Antiphospholipid Syndrome. Current Respiratory Medicine Reviews 5(2): 120-124, 2009

Successful Treatment of Concurrent Mucormycosis and Diffuse Alveolar Hemorrhage in a Patient With Newly Diagnosed Systemic Lupus Erythematosus. Archives of Rheumatology 33(2): 244-246, 2018